PAO Group Inc. PAOG, which operates as a physicians practice management company, confirmed its senior management team has obtained majority control of the company.
PAO Chief Executive James DiPrima has bought preferred stock from a third party and intends to continue serving at the helm of the company.
The management team has created a new medical cannabis strategy aimed to revitalize their "original mission to provide patient care alternatives to traditional patient care solutions," DiPrima explained.
The strategy includes the completion of the acquisitions of NCM Biotech from Kali-Extracts Inc. KALY, and a cannabis cultivation operation from Puration Inc. PURA, which are underway for months.
In addition, Puration announced the sale of its cultivation business on Friday.
The Dallas-based company had spun-off its cannabis cultivation operation to Nouveau NOUV earlier, in exchange for common stock.
"Our revitalization plan involves a complete exit of our previous endeavors and the implementation of an all new initiative through the planned acquisition of two currently operating businesses within the medical cannabis sector," DiPrima said.
Courtesy photo
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!